James Trager
Directeur Technique/Scientifique/R&D chez NKARTA, INC.
Fortune : 1 M $ au 30/04/2024
Postes actifs de James Trager
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NKARTA, INC. | Directeur Technique/Scientifique/R&D | 01/09/2016 | - |
Historique de carrière de James Trager
Anciens postes connus de James Trager
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DENDREON CORPORATION | Directeur Technique/Scientifique/R&D | 01/09/2003 | 01/12/2019 |
Formation de James Trager
| St. John's College | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NKARTA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- James Trager
- Expérience
